Beyond the Scope
Michael Quick, 2024 DPA President
Dec 19, 2024
Michael Quick, a cytologist and VP of R&D and Innovation at Hologic, discusses his journey in digital pathology and the innovative strides his company is making in this field. He highlights the integration of AI in cancer diagnostics and the pivotal role of diversity in driving innovation. Quick also reflects on the evolution of digital technologies and Hologic's significant focus on advancing women's health. In an exciting peek from Pathology Visions 2024, he shares his achievements as DPA President and the future potential of digital diagnostics.
20:55
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Michael Quick highlights the transformative role of digital technologies in cytology, improving diagnostic accuracy and enhancing workflows for better patient care.
- Under Michael Quick's leadership, the DPA has fostered growth and partnerships that advance digital pathology technologies and regulatory compliance.
Deep dives
Path to Innovation in Digital Pathology
The journey into digital pathology is marked by the need for innovation and adaptation within the field. Michael Quick, a seasoned cytologist, reflects on the challenges faced in traditional cytology, such as fatigue and the potential for diagnostic errors while searching for abnormal cells. He emphasizes the transformative opportunities presented by digital technologies, including whole slide imaging and the development of artificial intelligence algorithms tailored for cytology. These advancements not only enhance diagnostic accuracy but also streamline workflows, marking a significant evolution in how cytopathology can meet modern healthcare demands.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
